The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Ya-Qin Wang, MD PhD
- Phone Number: 86 15274810930
- Email: wdove.bb@163.com
Study Contact Backup
- Name: Chang-Qing Gao, MD PhD
- Phone Number: 86 188 7486 9488
- Email: cgao851@126.com
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410008
- Recruiting
- Center for Scientific Research with Animal Models, CSU
-
Contact:
- Ya-Qin Wang, MD PhD
- Phone Number: 152 7481 0930
- Email: wdove.bb@163.com
-
Contact:
- Chang-Qing Gao, MD PhD
- Phone Number: 86 188 7486 9488
- Email: cgao851@126.com
-
Principal Investigator:
- Chang-Qing Gao, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
- Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
- Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors
Description
Inclusion Criteria:
- Healthy volunteers who have been examined by the currently used procedures and find to be without tumors.
- Patients in the breast surgery, thoracic surgery, gynecological and neurosurgery departments with lesions with characteristics of tumors
Exclusion Criteria:
- Patients who have had pathological results
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Healthy volunteers
Healthy volunteers measured by currently used healthy screening procedures
|
|
Suspected breast cancer subjects
Suspected breast cancer subjects without pathological examination yet but will have it soon
|
|
Suspected lung cancer subjects
Suspected lung cancer subjects without pathological examination yet but will have it soon
|
|
Suspected neurological tumor subjects
Suspected neurological tumor subjects without pathological examination yet but will have it soon
|
|
Suspected patients with gynecological tumor
Suspected subjects with gynecological tumors without pathological examination yet but will have it soon
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sensitivity and specificity of the sniff dogs as a tool in diagnosing tumors
Time Frame: 12 months
|
The results that obtained from the dogs will be compared with these of the pathological examinations.
Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination.
Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination as non-cancer subjects.
|
12 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
behavior patterns of the sniff dogs to different diseases
Time Frame: 12 months
|
The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination.
|
12 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the substances used for identifying tumors by the sniff dogs
Time Frame: 12 months
|
GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from non-cancer subjects, the suspected VOCs will be tested by the dog for conformation.
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Chang-Qing Gao, MD PhD, Central South University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Xiang-Ya 0003
- XY 0003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.